Anti-ETL antibody
-
概述
- 产品描述developmental stage:Up-regulated in the adult heart. domain:The transmembrane domain is not required for cleavage, but it is required for dimer formation. Could be involved in cardiac development. PTM:Proteolytically cleaved into 2 subunits, an extracellular alpha subunit and a seven-transmembrane subunit. Belongs to the G-protein coupled receptor 2 family. LN-TM7 subfamily. Contains 1 GPS domain. Contains 2 EGF-like domains. subunit:Forms a heterodimer, consisting of a large extracellular region (alpha subunit) non-covalently linked to a seven-transmembrane moiety (beta subunit). Forms stable dimer at the cells surface. tissue specificity:Mainly expressed in smooth muscle.
- 产品名称Anti-ETL antibody
- 分子量77 kDa
- 种属反应性Human
- 验证应用WB,IF
- 抗体类型兔多抗
- 免疫原The antiserum was produced against synthesized peptide derived from human ELTD1. AA range:251-300
- 偶联Non-conjugated
-
性能
- 形态Liquid
- 浓度1 mg/mL.
- 存放说明Store at +4℃ after thawing. Aliquot store at -20℃ or -80℃. Avoid repeated freeze / thaw cycles.
- 存储缓冲液Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
- 亚型IgG
- 纯化方式Immunogen affinity purified.
- 其它名称ELTD1 antibody; ETL antibody; EGF antibody; latrophilin and seven transmembrane domain-containing protein 1 antibody; EGF-TM7-latrophilin-related protein antibody; ETL protein antibody;
-
应用
WB: 1:500-1:2000
IF: 1:100-1:500
特别提示：本公司的所有产品仅可用于科研实验，严禁用于临床医疗及其他非科研用途！
